A Phase I, Open Label, Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Intramuscular Injections of Letrozole ISM at Different Strengths in Voluntary Healthy Post Menopausal Women (LISA-1)
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2019
At a glance
- Drugs Letrozole (Primary) ; Letrozole
- Indications Breast cancer
- Focus Pharmacokinetics
- Acronyms LISA-1
- Sponsors Rovi
- 17 Jan 2019 Planned End Date changed from 1 Sep 2019 to 1 Jul 2020.
- 17 Jan 2019 Planned primary completion date changed from 1 Apr 2019 to 1 Jul 2020.
- 22 Jan 2018 New trial record